慢性创伤性脑损伤中选择性丘脑神经元丢失的结局与机制
这项跨断面研究在2个中心前瞻性收集2004年9月1日至2021年5月31日数据,纳入24例伤后>6个月的TBI患者(平均年龄39.2岁,18例男性)与33名健康对照(平均年龄47.6岁,23例男性),行[11C]氟马西尼(FMZ)PET。TBI患者伤后至扫描中位29个月(范围7-95),在左侧丘脑及双侧中央、内侧背、腹外侧背、前、腹前丘脑核团出现选择性神经元丢失,且超出总体体积丢失,跨越较广的损伤严重度范围。神经元丢失与GOS功能结局更差、持续执行注意认知结局更差及SF-36情绪结局更差相关。慢性丘脑神经元丢失部分与原发性皮质挫伤位置对应,可能提示跨神经元变性的继发性损伤机制。
要点
- 24例慢性TBI患者(伤后>6个月,中位29个月,范围7-95)与33名健康对照行FMZ PET,TBI组在左侧丘脑及双侧中央、内侧背、腹外侧背、前、腹前丘脑核团出现选择性神经元丢失。
- 丘脑神经元丢失超出总体体积丢失,跨越较广的损伤严重度范围,常规影像看似健康的组织也可检出。
- 神经元丢失与更差GOS功能结局相关(左侧丘脑、左侧腹前核及双侧中央、内侧背、前核)。
- 神经元丢失与持续执行注意认知结局更差相关(左侧丘脑、双侧中央核、右侧内侧背核),与SF-36情绪结局更差相关(右侧中央丘脑核)。
- 慢性丘脑神经元丢失部分与原发性皮质挫伤位置对应,可能提示跨神经元变性的继发性损伤机制。
适用人群与场景
- TBI伤后>6个月的患者,年龄>18岁,来自2个中心(英国剑桥大学和美国威尔康奈尔医学院)。
- 排除患有神经系统疾病、使用苯二氮䓬类药物或存在磁共振成像禁忌证的个体。
研究设计与关键结果
- 研究类型为跨断面研究,前瞻性收集2004年9月1日至2021年5月31日数据,回顾性整理,非连续招募(因便利性及扫描仪或PET配体可及性),共24例慢性TBI患者(平均年龄39.2[12.3]岁,18例男性[75.0%])和33名健康对照(平均年龄47.6[20.5]岁,23例男性[69.7%])行FMZ PET。
- TBI患者伤后至扫描中位时间29个月(范围7-95个月)。
- TBI患者在左侧丘脑及双侧中央、内侧背、腹外侧背、前、腹前丘脑核团出现选择性神经元丢失,超出左侧丘脑总体体积丢失,跨越较广的损伤严重度范围。
- 神经元丢失与更差GOS功能结局相关(左侧丘脑、左侧腹前核及双侧中央、内侧背、前核)。
- 神经元丢失与持续执行注意认知结局更差相关(左侧丘脑、双侧中央核、右侧内侧背核)。
- 神经元丢失与SF-36情绪结局更差相关(右侧中央丘脑核)。
- 慢性丘脑神经元丢失部分与原发性皮质挫伤位置对应,可能提示跨神经元变性的继发性损伤机制。
证据类型、等级与局限
- 证据类型:跨断面研究,2个中心。
- 数据回顾性整理,非连续招募,因便利性及扫描仪或PET配体可及性。
- 局限:原文报告非连续招募;余原文未报告局限性。
对床旁实践的改变
- 作者认为,FMZ PET是比常规影像更敏感的神经元损伤负荷标志物,可用于结局预后判断,并可能推动个体化精准医学方法的发展。
- 作者认为,选择性丘脑易损性可能具有慢性神经元后果并与长期结局相关,提示TBI的丘脑神经元后果可能持续演变并可能终身存在。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The chronic neuronal burden of traumatic brain injury (TBI) is not fully characterized by routine imaging, limiting understanding of the role of neuronal substrates in adverse outcomes.
OBJECTIVE: To determine whether tissues that appear healthy on routine imaging can be investigated for selective neuronal loss using [11C]flumazenil (FMZ) positron emission tomography (PET) and to examine whether this neuronal loss is associated with long-term outcomes.
DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study, data were collected prospectively from 2 centers (University of Cambridge in the UK and Weill Cornell Medicine in the US) between September 1, 2004, and May 31, 2021. Patients with TBI (>6 months postinjury) were compared with healthy control participants (all aged >18 years). Individuals with neurological disease, benzodiazepine use, or contraindication to magnetic resonance imaging were excluded. Data were retrospectively collated with nonconsecutive recruitment, owing to convenience and scanner or PET ligand availability. Data were analyzed between February 1 and September 30, 2023.
EXPOSURE: Flumazenil voxelwise binding potential relative to nondisplaceable binding potential (BPND).
MAIN OUTCOMES AND MEASURES: Selective neuronal loss identified with FMZ PET was compared between groups on voxelwise and regional scales, and its association with functional, cognitive, and psychological outcomes was examined using Glasgow Outcome Scale (GOS) scores, measures of sustained executive attention (animal and sustained fluency), and 36-Item Short Form Health Survey (SF-36) scores. Diffusion tensor imaging was used to assess structural connectivity of regions of cortical damage, and its association with thalamic selective neuronal loss.
RESULTS: In this study, 24 patients with chronic TBI (mean [SD] age, 39.2 [12.3] years; 18 men [75.0%]) and 33 healthy control participants (mean [SD] age, 47.6 [20.5] years; 23 men [69.7%]) underwent FMZ PET. Patients with TBI had a median time of 29 (range, 7-95) months from injury to scan. They displayed selective neuronal loss in thalamic nuclei, over and above gross volume loss in the left thalamus, and bilateral central, mediodorsal, ventral-lateral dorsal, anterior, and ventral anterior thalamic nuclei, across a wide range of injury severities. Neuronal loss was associated with worse functional outcome using GOS scores (left thalamus, left ventral anterior, and bilateral central, mediodorsal, and anterior nuclei), worse cognitive outcome on measures of sustained executive attention (left thalamus, bilateral central, and right mediodorsal nuclei), and worse emotional outcome using SF-36 scores (right central thalamic nucleus). Chronic thalamic neuronal loss partially mirrored the location of primary cortical contusions, which may indicate secondary injury mechanisms of transneuronal degeneration.
CONCLUSIONS AND RELEVANCE: The findings of this study suggest that selective thalamic vulnerability may have chronic neuronal consequences with relevance to long-term outcome, suggesting the evolving and potentially lifelong thalamic neuronal consequences of TBI. FMZ PET is a more sensitive marker of the burden of neuronal injury than routine imaging; therefore, it could inform outcome prognostication and may lead to the development of individualized precision medicine approaches.
参考来源
- Woodrow RE, Grossac J, Hong YT, et al. Outcomes and Mechanisms Associated With Selective Thalamic Neuronal Loss in Chronic Traumatic Brain Injury. JAMA Netw Open. 2024. PMID: 39106064. doi:10.1001/jamanetworkopen.2024.26141
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。